Class IITerminatedD-1807-2019
Drug recall · August 21, 2019
RAMUCIRUMAB 457 MG QS 250 ML NS IVPB recall
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
RAMUCIRUMAB 457 MG QS 250 ML NS IVPB; AMUCIRUMAB 1182 MG QS 250 ML NS IVPB; Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
- Lots / codes
All lots within expiry
- Quantity
- N/A
- Company
- Infusion Options, Inc., Brooklyn, NY
- Distribution
- NY only
- Initiated
- June 12, 2019 · Voluntary: Firm initiated
- Classified
- August 15, 2019
- Reported
- August 21, 2019
- Ended
- March 21, 2025
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class IITerminatedAug 21, 2019Oxytocin 60 units/1000 mL Lactated Ringers Intravenous SolutionInfusion Options, Inc. · D-1744-2019Class IITerminatedAug 21, 2019Abraxane 170 MG / 34 ML IVPBInfusion Options, Inc. · D-1745-2019Class IITerminatedAug 21, 2019Adcetris 96 MG/100 ML NS IVPBInfusion Options, Inc. · D-1746-2019Class IITerminatedAug 21, 2019ADO-TRASTUZUMAB 210 MG/250 ml NSInfusion Options, Inc. · D-1747-2019Class IITerminatedAug 21, 2019ALIMTA 785 mg QS 100 ml 0.9% NACL IVPBInfusion Options, Inc. · D-1748-2019Class IITerminatedAug 21, 2019ATEZOLIZUMAB 1200 MG / 250 ML 0.9% NACLInfusion Options, Inc. · D-1749-2019Class IITerminatedAug 21, 2019AVASTIN 630 MG / 100 ML 0.9% NACL IVPBInfusion Options, Inc. · D-1750-2019Class IITerminatedAug 21, 2019AZACITIDINE 125 MG / 5 ML SUB-Q SYRINGEInfusion Options, Inc. · D-1751-2019Class IITerminatedAug 21, 2019BEVACIZUMAB 784 MG / 100 ML NS IVPBInfusion Options, Inc. · D-1752-2019Class IITerminatedAug 21, 2019BLEOMYCIN 18 UNITS / 100 ML NS IVPBInfusion Options, Inc. · D-1753-2019Class IITerminatedAug 21, 2019BORTEZOMIB 2.5 mg / 1 ML SQ SYRINGEInfusion Options, Inc. · D-1754-2019Class IITerminatedAug 21, 2019CALCIUM GLUCONATE 1 GM /100 ML NACL 0.9% IVPBInfusion Options, Inc. · D-1755-2019
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.